Transformed Ironclad All Set For Growth in 2015 post image

Ironclad Performance Wear (ICPW – $0.29), a leader in technical, task-specific, and performance work gloves, has gone through a complete transformation the past few quarters. It has streamlined its operations, favorably renewed existing agreements and formed new partnerships, which will soon result in many new product introductions.

Since Jeff Cordes took the helm at Ironclad in February 2014, the Company focused on rebuilding its largest accounts, developing better products, leveraging its marketing to create compelling products that retailers want, building a capable sales team, and expanding the supplier base of manufacturers nearly four-fold.

All these efforts have positioned the Company to be more competitive and ready for substantial growth in 2015 and beyond. [click to continue…]

Why 2015 Will Be Even Better Than 2014 post image

Acme United (ACU – $18.25) achieved record sales in all four quarters of fiscal year 2014. Looking at the number of products that are set to be launched, the synergies in the first aid business and the internal growth, we believe the Company will repeat that feat in 2015.

In the first and second quarter of 2015, for example, sales will see the contribution of First Aid Only for the first time, as it was acquired mid-2014. Acme’s three first aid brands are broadening their line of first aid kits and expanding the refill business, which positions them ideally with office products & mass market customers, and sporting goods dealers. The first aid business now accounts for 35% of Acme’s total revenues.

At the SHOT Show in January 2015, a great deal of new products were launched. Camillus presented the completely re-designed Carnivore X machete, the ‘Seven’ series folding knife line and an updated version of the highly successful Heat, Sizzle and Wildfire knives. Also, the once popular Western knife brand was re-launched with all new designs, packaging and branding. These tools will all hit the stores in 2015. [click to continue…]

Uranium Spot Price Edges Higher as Restart Japanese Nuclear Plants Nears post image

Since our initial recommendation of Azarga Uranium Corp (TSXV:AZZ – $0.41 CAD & Frankfurt:P8AA – $0.29 EUR) the uranium spot price has gradually increased about 6% to $39.25/lb today (see image below).

The main reason for this rise is that Japan could restart some of its nuclear reactors as soon as May 2015. Remember that most of Japan’s 48 operational reactors have been idled since the 9.0-magnitude Tohoku earthquake and ensuing tsunami in March 2011.

That disaster caused the meltdown at the Fukushima Daiichi Nuclear Power Plant, which resulted in Japan suspending all its nuclear power generation. Because, at the time, the country utilized approximately 15% of global uranium demand – second most after the United States – this decision had a devastating impact on the atomic fuel’s price.

Now that Japan’s Nuclear [click to continue…]

EnWave Corporation On the Brink of Becoming Cash Flow Positive post image

EnWave Corporation (TSXV:ENW – $1.09 CAD & OTC:NWVCF – $0.86 USD) offers industrial-scale dehydration technology for commercial applications in the food and pharmaceutical spaces. The Company’s Radiant Energy Vacuum (“REV”) platforms are becoming the new global dehydration standard: faster and cheaper than freeze drying, and with better end product quality than air drying or spray drying.

Judging from the large and well-known companies with which EnWave has signed commercial licenses or research collaborations, it’s clear that its REV technology is a game changer. Moreover, EnWave hardly has any competition and its technology is fully patented, which enhances the Company’s valuation.

Sales for the first quarter of fiscal year 2015, ended December 31, 2014, reached $2.51 million, an increase of $1.94 million, or 343%, compared with the same quarter last year. The strong increase was mostly driven by EnWave’s German subsidiary’s success in securing machine-building contracts and by its 51% owned subsidiary NutraDried, which generated more sales during the first quarter of fiscal year 2015 (approximately USD$450,000), than it produced for the FULL fiscal year 2014 (USD$220,000). [click to continue…]

IsoRay Continues To Make Waves In Cancer Treatment Market post image

IsoRay, Inc. (ISR – $1.57), our favorite medical technology Company, is an innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head, neck and gynecological cancers.

IsoRay is the exclusive manufacturer of Cesium-131, which allows for the precise treatment of many different cancers thanks to its unrivaled blend of high energy and its 9.7 day half-life (its unequaled speed in giving off therapeutic radiation). Cesium-131 is FDA-cleared and holds a CE mark for international sales in seed form.

A few weeks ago, the University of Pittsburg Medical Center (UPMC) released a peer-reviewed publication supporting the use of Cesium-131 for prostate cancer. The report covers a 9 year effort of using Cesium-131 for the treatment of low and intermediate prostate cancer. The conclusion was: Cesium-131 seed brachytherapy offers extremely high efficacy compared to [click to continue…]

Smallcaps Finds Out if Acme United Record 2014 Results Can Be Sustained post image

Although Acme United (ACU – $19.04) only recently announced record sales and earnings for 2014, investors are already eagerly looking forward to find out if that momentum can be sustained. So we sat down with Mr. Walter C. Johnsen, Chairman and CEO of Acme, to extensively discuss the Company’s growth opportunities.

Mr. Johnsen delivers plenty of valuable information about Acme’s first aid business, that thanks to the First Aid Only acquisition, contributed about 35% of the Company’s total revenues in 2014. He discusses the cost savings achieved by combining Acme’s three first aid brands and their potential.

The interview digs deeper into the Company’s other brands, such as Westcott. The CEO provides us with information on the iPoint electric pencil sharpener’s phenomenal success and adds [click to continue…]

Goldsource Advances Eagle Mountain Gold Project Towards Production post image

Due to lack of funds, very few precious metals projects have been taken into production over the past few years. Goldsource Mines (TSXV: GXS – 0.18 CAD & Frankfurt: G5M – 0.13 EUR) however, will accomplish that feat in 2015 at its Eagle Mountain Gold Project located in Guyana, South America.

The Company raised the necessary capital to complete the Phase I mine and processing plant construction in December last year. Since then, Goldsource has been extremely busy with engineering work, initial mining equipment purchases, pre‐production development and construction of facilities.

In addition, the existing 10 kilometre access road between the Eagle Mountain Gold project and Mahdia town, which connects with the main interior highway and commercial airport, is being rehabilitated. The Mahdia community is also the primary source for skilled workers. [click to continue…]